184 related articles for article (PubMed ID: 28303966)
21. Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.
Sudha T; Bharali DJ; Yalcin M; Darwish NH; Debreli Coskun M; Keating KA; Lin HY; Davis PJ; Mousa SA
Int J Nanomedicine; 2017; 12():1305-1315. PubMed ID: 28243091
[TBL] [Abstract][Full Text] [Related]
22. Covalent attachment of Mn-porphyrin onto doxorubicin-loaded poly(lactic acid) nanoparticles for potential magnetic resonance imaging and pH-sensitive drug delivery.
Jing L; Liang X; Li X; Yang Y; Dai Z
Acta Biomater; 2013 Dec; 9(12):9434-41. PubMed ID: 23962645
[TBL] [Abstract][Full Text] [Related]
23. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
24. A lupus anti-DNA autoantibody mediates autocatalytic, targeted delivery of nanoparticles to tumors.
Chen Z; Patel JM; Noble PW; Garcia C; Hong Z; Hansen JE; Zhou J
Oncotarget; 2016 Sep; 7(37):59965-59975. PubMed ID: 27494868
[TBL] [Abstract][Full Text] [Related]
25. Effects of surfactants on the properties of PLGA nanoparticles.
Menon JU; Kona S; Wadajkar AS; Desai F; Vadla A; Nguyen KT
J Biomed Mater Res A; 2012 Aug; 100(8):1998-2005. PubMed ID: 22566409
[TBL] [Abstract][Full Text] [Related]
26. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation.
Wang J; Li L; Wu L; Sun B; Du Y; Sun J; Wang Y; Fu Q; Zhang P; He Z
Eur J Pharm Sci; 2017 Mar; 99():185-192. PubMed ID: 27989702
[TBL] [Abstract][Full Text] [Related]
27. Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles.
Chittasupho C; Lirdprapamongkol K; Kewsuwan P; Sarisuta N
Eur J Pharm Biopharm; 2014 Oct; 88(2):529-38. PubMed ID: 25119723
[TBL] [Abstract][Full Text] [Related]
28. Nano-loaded human umbilical cord mesenchymal stem cells as targeted carriers of doxorubicin for breast cancer therapy.
Cao S; Guo J; He Y; Alahdal M; Tang S; Zhao Y; Yang Z; Gao H; Hu W; Jiang H; Qin L; Jin L
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):642-652. PubMed ID: 29457930
[TBL] [Abstract][Full Text] [Related]
29. Preparation and drug release mechanism of CTS-TAX-NP-MSCs drug delivery system.
Dai T; Yang E; Sun Y; Zhang L; Zhang L; Shen N; Li S; Liu L; Xie Y; Wu S; Gao Z
Int J Pharm; 2013 Nov; 456(1):186-94. PubMed ID: 23933442
[TBL] [Abstract][Full Text] [Related]
30. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
[TBL] [Abstract][Full Text] [Related]
31. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
[TBL] [Abstract][Full Text] [Related]
32. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
Wu J; Tang C; Yin C
Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
[TBL] [Abstract][Full Text] [Related]
33. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568
[TBL] [Abstract][Full Text] [Related]
34. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
[TBL] [Abstract][Full Text] [Related]
35. Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice.
Zhang TY; Huang B; Wu HB; Wu JH; Li LM; Li YX; Hu YL; Han M; Shen YQ; Tabata Y; Gao JQ
J Control Release; 2015 Jul; 209():260-71. PubMed ID: 25966361
[TBL] [Abstract][Full Text] [Related]
36. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori.
Luo M; Jia YY; Jing ZW; Li C; Zhou SY; Mei QB; Zhang BL
Colloids Surf B Biointerfaces; 2018 Apr; 164():11-19. PubMed ID: 29367052
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal stem cells-curcumin loaded chitosan nanoparticles hybrid vectors for tumor-tropic therapy.
Xu M; Asghar S; Dai S; Wang Y; Feng S; Jin L; Shao F; Xiao Y
Int J Biol Macromol; 2019 Aug; 134():1002-1012. PubMed ID: 31063785
[TBL] [Abstract][Full Text] [Related]
38. Development of porous PLGA/PEI1.8k biodegradable microspheres for the delivery of mesenchymal stem cells (MSCs).
Lee YS; Lim KS; Oh JE; Yoon AR; Joo WS; Kim HS; Yun CO; Kim SW
J Control Release; 2015 May; 205():128-33. PubMed ID: 25575866
[TBL] [Abstract][Full Text] [Related]
39. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
40. Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy.
Takayama Y; Kusamori K; Tsukimori C; Shimizu Y; Hayashi M; Kiyama I; Katsumi H; Sakane T; Yamamoto A; Nishikawa M
J Control Release; 2021 Jan; 329():1090-1101. PubMed ID: 33098911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
